Griseofulvin 250 mg Oral Capsule
RxNorm 239237
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 239237 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: griseofulvin 250 mg Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Griseofulvin 250 mg Oral Capsule
(Atom ID: 12325475)
PSN
Prescribable Name (PSN):
Griseofulvin 250 mg Oral Capsule
(Atom ID: 6369511)
PT
Designated preferred name (PT):
Griseofulvin 250 mg oral capsule
(Atom ID: 10299384)
PT
Designated preferred name (PT):
Griseofulvin microsize 250 mg oral capsule
(Atom ID: 10299385)
FN
Full form of descriptor (FN):
Product containing precisely griseofulvin 250 mg/1 each conventional release oral capsule (clinical drug)
(Atom ID: 10313147)
FN
Full form of descriptor (FN):
Product containing precisely griseofulvin microsize 250 mg/1 each conventional release oral capsule (clinical drug)
(Atom ID: 10313155)
Patient Education
Griseofulvin
Griseofulvin is used to treat skin infections such as jock itch, athlete's foot, and ringworm; and fungal infections of the scalp, fingernails, and toenails. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
[Learn More]
* Please review the disclaimer below.